Delivery Order SPE2DB20D3103-SPE2DB23FP0Q5
Award Date
7/20/23
Potential Completion Date
7/21/23
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $15,861.69, is for the delivery of REMICADE 100 MG VIALS, a specialty medication. The contract has a period of performance through March 13, 2024 and is structured as a firm fixed-price delivery order. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REMICADE 100 MG VIALS. The $75,150.30 delivery order contract is a firm fixed-price arrangement with an ultimate completion date of September 16, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to...
This federal contract award, valued at $14,062.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4557853181 - REMICADE 100 MG VIALS, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a completion date of July 21, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUG84, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,591.10 firm fixed-price delivery order contract is for the supply of 4567038437 REMICADE 100 MG VIALS, a critical pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. Amerisourcebergen holds a significant...
This federal contract award, valued at $14,536.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566598452 REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of December 4, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FDPD5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,140.58 delivery order is for the provision of 4562983414 REMICADE 100 MG VIALS, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 5, 2023. The contract was awarded on December 4, 2022 and was not set aside for any specific business type....
This federal contract award, valued at $11,245.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under the DLA's Indefinite Delivery Contract (IDC) for medical commodities, with a firm fixed price and an ultimate completion date of January 13, 2025. The contract covers the procurement of REMICADE 100 MG VIALS, a specialty pharmaceutical product, to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,330.24 firm fixed-price delivery order is for the supply of REMICADE 100 mg vials, a specialty pharmaceutical product. The contract has a period of performance through May 10, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the Department of Defense and...
This federal contract award, with ID SPE2DB22D1202|SPE2DB24FVCA5, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,469.60 delivery order contract is for the supply of REMICADE 100 MG VIALS, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of June 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB23FGV11, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4560665222 REMICADE 100 MG VIALS, with a ceiling value of $34,369.13 and a completion date of April 21, 2023. The contract is a Delivery Order under a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...